Concentration-reinfusion (CR) of ascitic of ascitic fluid in the treatment of decompensated liver cirrhosis with diuretic-resistant ascites

腹水浓缩回输(CR)治疗利尿剂抵抗性腹水的失代偿期肝硬化

阅读:1

Abstract

The ascites concentration-reinfusion as current therapeutic procedure is probably too expensive (but less expensive than desalinated human albumin) and in our opinion it is not a substitute for the diuretic drugs in diuretic-responsive ascites. On the other hand, this method plays an important role in the management of diuretic-resistant ascites. The mechanical extraction of the sequestered fluid and the infusion of a concentrated derivative into the blood stream beyond the portal blockade aim to restore the ‘effective’ blood volume, renal perfusion and GFR. This effect may induce a new responsive state of the kidney to diuretic drugs and may correct the functional renal failure. In addition, a well concentrated ascites supplies autologous proteins to those patients with gross abnormalities of serum protein concentrations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。